BioNote, Inc. (KRX:377740)

South Korea · Delayed Price · Currency is KRW

5,190.00

+60.00 (1.17%)

At close: Apr 24, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Animal			65.64B	67.30B	57.67B	-	-
Animal Growth			-2.47%	16.70%	-	-	-
Life Science			24.44B	416.25B	566.41B	-	-
Life Science Growth			-94.13%	-26.51%	-	-	-
Inter-Segment Revenue			-	-3.90B	-1.73B	-	-
Diagnostic Kits / Equipment			-	-	-	631.50B	40.05B
Diagnostic Kits / Equipment Growth			-	-	-	1476.89%	-
Total			90.08B	479.66B	622.36B	631.50B	40.05B
Total Growth			-81.22%	-22.93%	-1.45%	1476.89%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea			35.34B	390.07B	522.15B	533.63B	17.48B
South Korea Growth			-90.94%	-25.30%	-2.15%	2952.01%	-
Overseas			54.74B	89.59B	100.21B	-	22.56B
Overseas Growth			-38.90%	-10.60%	-	-	-
America			-	-	-	5.87B	-
Africa			-	-	-	351.94M	-
Europe			-	-	-	14.80B	-
Asia			-	-	-	76.37B	-
Oceania			-	-	-	476.40M	-
Total			90.08B	479.66B	622.36B	631.50B	40.05B
Total Growth			-81.22%	-22.93%	-1.45%	1476.89%	-

Source: S&P Global Market Intelligence.